Tiefenbacher Group: Three Successful Days at CPHI 2021 in Milano - Thank you for visiting us
With over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma eventt CPHI has just come to an end. It was three very successful days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations at Fiera Milano. After two years of mainly digital work it was a great experience to finally meet our valued customers and partners in person again. Our experts have come home with lots of new inspirations and business ideas and are already looking forward to reconnecting soon. Check out our short video to get an impression of our brand-new booth representing TIEFENBACHER GROUP as a global health pioneer.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
